Klick Health Unveils AI-Driven Social Media Tool for Pharma

Klick Health has released the Klick Comment Moderator+AI (KCM+AI), which introduces artificial intelligence capabilities to its existing social media comment moderation tool. The AI-enhanced version, powered by Microsoft Azure AI and a proprietary Klick model trained on almost 400,000 historical comments, aims to improve pharmacovigilance detection and streamline community management across platforms like Facebook and Instagram.

Potential Enhancements in Pharmacovigilance

The KCM+AI tool is designed to enhance the detection of adverse events and product complaints with a reported accuracy of over 95%, incorporating two layers of human moderation to ensure comprehensive coverage. This tool automatically flags and hides comments for moderation, which are then routed to Klick’s community managers and the Science & Regulatory team.

“We’ve trusted Klick’s KCM for years to ensure our social media engagement is both safe and compliant, and the leap to KCM+AI brings exciting prospects,” stated Rich Muser, Executive Director, Digital Strategy & Development at Acorda Therapeutics.

Michael Russo, Acorda’s Vice President of Digital Strategy and Innovation, also expressed optimism: “Its advanced AI capabilities promise to revolutionize pharmacovigilance with efficiency and smarter moderation, something pharma is eager to embrace.”

Strategic Benefits and Future Outlook

Brad Einarsen, Klick’s Senior Vice President, Strategic Futures, highlighted the strategic value of integrating social channels within existing marketing frameworks. “We see KCM+AI as a digital assistant that keeps our clients’ brands more protected from pharmacovigilance issues, while enabling our community managers to focus on higher-level work,” he explained.

KCM+AI is now available to all Klick clients and supports Meta platforms, with plans to extend its capabilities to other social media platforms in the future. The tool represents Klick Health’s ongoing commitment to leveraging AI for enhancing client outcomes in the highly regulated pharmaceutical industry.

Questions from Solli

• Geo customisation: Is this tool able to be customised to the specific geography in which the client or comments appears?
• Customer customisation: In the knowledge that Pharma companies often interpret the same regulations in slightly different ways, can this tool be tailored to each clients’ interpretations?
• Feedback loop: How can the automation feed into a continuous loop of feedback and content iteration?

The full press release can be read here.